Cervical cancer is a real public health problem in Peru and countries called developing world, a problem that could not be controlled despite having the weapons to do so. We refer to secondary prevention through cytological screening in industrialized countries has significantly lower rates of incidence and mortality of this malignancy. Apparently, there is no reason for this success is not repeated in developing countries, but a deeper analysis leads us to believe that the classic system based on cervical cytology requires frequent repetition of the screening test, trained personnel, resources and organization, elements that do not have most of these countries.

The aim of this communication is to review some research contribution in Peru on the relationship of human papilloma virus and cervical cancer.

Cervical cancer is a real public health problem in Peru and countries called developing world, a problem that could not be controlled despite having the weapons to do so. We refer to secondary prevention through cytological screening in industrialized countries has significantly lower rates of incidence and mortality of this malignancy. Apparently, there is no reason for this success is not repeated in developing countries, but a deeper analysis leads us to believe that the classic system based on cervical cytology requires frequent repetition of the screening test, trained personnel, resources and organization, elements that do not have most of these countries.

The aim of this communication is to review some research contribution in Peru on the relationship of human papilloma virus and cervical cancer.

Gynecologic cancer epidemiology in Peru. National program of promotion and cancer prevention. Role of centers of excellence in the prevention and treatment of cervical cancer. Scientific validity of the arguments against the HPV vaccine. Breast cancer in Peru.

Of the 17.326 patients with cervical cancer registered in the INEN between 1952 and 1979, 403 were 76 years or older at diagnosis (2.3%). The average age in this group was 80.6 years and older was 99 years. The first sex was at 19 and the average latency period 61 years, in contrast to 16 and seven years for the group of 123 patients under 25 years. The distribution showed predominance of clinical stay in the añosas advanced disease, although the parametrial involvement (comparison between stays A and B) was significantly lower (p <0.001) than in young, possibly due to anatomical changes involution. Squamous cell carcinoma was the predominant type and significantly more frequent (98%) in those over 76, with lower incidence of adenocarcinoma and mucoepidermoid carcinoma. The linioplasmocitario cervical stromal infiltrate was more frequent in younger patients, in which an inverse relation...

Of the 17.326 patients with cervical cancer registered in the INEN between 1952 and 1979, 403 were 76 years or older at diagnosis (2.3%). The average age in this group was 80.6 years and older was 99 years. The first sex was at 19 and the average latency period 61 years, in contrast to 16 and seven years for the group of 123 patients under 25 years. The distribution showed predominance of clinical stay in the añosas advanced disease, although the parametrial involvement (comparison between stays A and B) was significantly lower (p <0.001) than in young, possibly due to anatomical changes involution. Squamous cell carcinoma was the predominant type and significantly more frequent (98%) in those over 76, with lower incidence of adenocarcinoma and mucoepidermoid carcinoma. The linioplasmocitario cervical stromal infiltrate was more frequent in younger patients, in which an inverse relat...